Expandimos los horizontes en el uso de la medicina nuclear en Latinoamérica con herramientas de AI y recurso humano altamente capacitado.
Joined February 2022
- Tweets230
- Following110
- Followers165
- Likes215
Nuclear Medicine World retweeted
The power of #teamwork.
Congratulations @dandanmena for the excellent presentation in ASCO GU 2025!!
@UroTeragLATAM @nmwlatam – at San Francisco, CA
Nuclear Medicine World retweeted
Is there a role for PSMA PET/CT in oligometatastic RCC?
Check out our @JournalofNucMed PEDESTAL study on PSMA-guided metastasis-directed therapy from @PeterMacCC @_ShankarSiva @DrMHofman
🧍33 pts & 60 metastases
🛜 93% radiotherapy
📖Median follow-up> 4y
✅Local control: 94% at 1y, 85% at 3y
✅Freedom from change (or commencement) of systemic therapy: 76% at 1y, 65% at 3y
Nuclear Medicine World retweeted
¹⁷⁷Lu-rhPSMA-10.1 is a promising next-generation radiopharmaceutical therapy for prostate cancer. Learn more: ow.ly/F3iO50VjuSn
#NuclearMedince #RPTherapy #ProstateCancer @NuclearMedEd
Nuclear Medicine World retweeted
... how common is PSMA-negative significant prostate
cancer? In the proPSMA study it was 3.3%
Hot of the press in @JournalofNucMed: jnm.snmjournals.org/content/…
Wonderful work from @davcmed and team @pros_tic including @ButeauJames @declangmurphy
Nuclear Medicine World retweeted
Kicking off the inaugural edition of APCCC Diagnostics with two NEJM first authors … @veerukasi Prof. Jonas Hugosson. More to come over the next days. @APCCC_Lugano @stefanofanti4 @LoebStacy @Silke_Gillessen @DrMHofman @DrSpratticus @TylerSbrt @ProfHadaschik
Nuclear Medicine World retweeted
10 BECAS DE INSCRIPCIÓN PARA EL UROTERAGLATAM 2025
“Asiste al evento Uro-Teragnóstico multidisciplinario más grande de Latinoamérica”
INSCRIPCIONES : uroteraglatam.com/
CANCÚN CENTER – MÉXICO 11 Y 12 MARZO
BECAS : caunet.org/news/10-becas-par…
Nuclear Medicine World retweeted
One year ago we published the @ANZUPtrials #TheraP follow-up... the Appendix contains the answers to many questions I am often asked. Three of my favourite Figures below:
1) Survival in patients who had FDG-discordant or low PSMA-expression and were not randomised vs. LuPSMA/cabazitaxel
2) Survival by PSA response. PSA≥90 had a hazard ratio of 0.34 !!
3) Prognostic power of FDG PET/CT (metabolic tumour volume) for survival - the single most powerful parameter
thelancet.com/journals/lanon…
@MovemberAUS @PCF_Science
Nuclear Medicine World retweeted
🗞️ News! Asiste al evento Uro-Teragnóstico Multidisciplinario más grande de LATAM.
11 y 12 de marzo - Cancún 🇲🇽
🔥 40% de descuento para ex alumnos/as de nuestro curso o quienes se han inscripto este año. Solicita tu código.
Reserva tu lugar! 👉 uroteraglatam.com/
Nuclear Medicine World retweeted
Friends at #GU25 Inviting you to JOIN US at #APCCCDiagnostics25 🇨🇭in Lugano
A HYBRID Meeting (In Person & Live) Switzerland February 27-28, 2025
REGISTER: apccc.org/apccc-diagnostics-…
ONLINE REGISTRATION FOR LMIC's FREE
OncoAlert 🚨Will be Live in Lugano with Coverage
In recent years, diagnostic capabilities for #ProstateCancer have significantly advanced through innovations in imaging, biomarkers, and the introduction of PSMA PET imaging, which have reshaped traditional diagnostic approaches. To address these advancements and their growing relevance in early detection, a new conference series, APCCC Diagnostics, will launch in February 2025 in Lugano, Switzerland, focusing on Prostate #Cancer diagnostics.
Scientific Committee
@ProfKHerrmann🇩🇪
@stefanofanti4 🇮🇹
@Silke_Gillessen 🇨🇭
@AOmlin 🇨🇭
Ambassadors
@ZilliThomas 🇨🇭
@nataliagandur 🇦🇷
@LoebStacy 🇺🇸
@bavilima 🇧🇷
@fabioturco92 🇨🇭
@DrYukselUrun 🇹🇷
@weoncologists 🇺🇸
The #APCCCDiagnostics Panel
@bjartell
@Albert0Briganti
@Ecastromarcos
@drlouiseemmett
@DrAGafita
@karolien_goffin
@ProfHadaschik
@DrMHofman
@Prof_Nick_James
@piet_ost
@gpalapa2
@MoniqueRoobol
@TylerSbrt
@DrSpratticus
@Tilki_De
@BertrandTOMBAL
@Nina18205
@UrsulaVogl
@ResearchWyatt
Nuclear Medicine World retweeted
Andrei Iagaru highlighting the relative cost of FDG, PSMA and Pluvicto. $2500 can $6500 vs $300,000 ! "I'm not a health economist but it seems FDG may be cost effective" #FelixFeng symposium @ASCO #GU25 – at San Francisco, CA
Nuclear Medicine World retweeted
Lead-212 (²¹²Pb) DOTAMTATE could potentially offer a more effective targeted α-therapy treatment option for SSTR2-positive neuroendocrine tumours
jnm.snmjournals.org/content/…
Nuclear Medicine World retweeted
SPECT deserves RESPECT!
@drlouiseemmett makes the argument that it is a powerful tool for theranostics ➤ enabling early, personalised treatment response evaluation ➤ optimizes outcomes by guiding therapy adjustments.
✓practical advantages over serial PET.
jnm.snmjournals.org/content/…
@JournalofNucMed
Nuclear Medicine World retweeted
Low- and High-Volume Disease in mHSPC:
from CHAARTED to #PSMA PET
#stagemigration
jnm.snmjournals.org/content/…
@UnterrainerLena @JournalofNucMed @thomashopemd @UCLAHealth @SathegkeM @AmarUKishan @CzerninJohannes @ProfKHerrmann @Wes_Armstrong_
Nuclear Medicine World retweeted
It's been a busy 2024 @pros_tic with clinical trials, discovery research & education all progressing at pace
We've put together a podcast of highlights:
youtu.be/l-KEkK1H2ew?feature…
@PCF_Science – at Melbourne, Victoria
Nuclear Medicine World retweeted
A real-world comparison of cabazitaxel versus ¹⁷⁷Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer: ow.ly/EH3850U9Bl7
#NuclearMedicine #RPTherapy #ProstateCancer @MarkusGraefen @carosiech
Nuclear Medicine World retweeted
ICPO Foundation and Prof. Richart P. Baum (@baumrp) applauds new radiotherapy and theranostics report of the Lancet Oncology Commission. Three ICPO SAB members @DrMHofman Michael Hofman, Mike Sathekge and Andrew Scott participated in the report.
Nuclear Medicine World retweeted
¹⁷⁷Lu-PSMA-617 showed antitumor activity and a favorable toxicity profile for patients with PSMA-positive mCRPC in a real-world setting. ow.ly/9RhK50TrUn2
#NuclearMedicine #ProstateCancer #RPTherapy @DrAGafita @radnucmp @MarkowskiGUOnc @AveryS32342
Nuclear Medicine World retweeted
Reserva la fecha 📆! Te esperamos en @IAF_Fleming – at Ciudad Autónoma de Buenos Aires, Argentina
Nuclear Medicine World retweeted
No te lo pierdas.... Últimos días para inscribirse curso @UroTeragLATAM!!
